Montag & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
510
+25
| +5% | +$11.1K | 0.01% | 382 |
|
|
2025
Q1 | $235K | Hold |
485
| – | – | 0.01% | 398 |
|
|
2024
Q4 | $195K | Sell |
485
-462
| -49% | -$186K | 0.01% | 427 |
|
|
2024
Q3 | $440K | Buy |
947
+39
| +4% | +$18.1K | 0.02% | 337 |
|
|
2024
Q2 | $426K | Buy |
908
+473
| +109% | +$222K | 0.02% | 328 |
|
|
2024
Q1 | $182K | Buy |
435
+50
| +13% | +$20.9K | 0.01% | 424 |
|
|
2023
Q4 | $157K | Buy |
385
+200
| +108% | +$81.4K | 0.01% | 426 |
|
|
2023
Q3 | $64.3K | Hold |
185
| – | – | ﹤0.01% | 508 |
|
|
2023
Q2 | $65.1K | Sell |
185
-3
| -2% | -$1.06K | ﹤0.01% | 512 |
|
|
2023
Q1 | $59.2K | Hold |
188
| – | – | ﹤0.01% | 521 |
|
|
2022
Q4 | $54.3K | Buy |
188
+19
| +11% | +$5.49K | ﹤0.01% | 528 |
|
|
2022
Q3 | $49K | Hold |
169
| – | – | ﹤0.01% | 538 |
|
|
2022
Q2 | $48K | Hold |
169
| – | – | ﹤0.01% | 535 |
|
|
2022
Q1 | $44K | Hold |
169
| – | – | ﹤0.01% | 589 |
|
|
2021
Q4 | $37K | Hold |
169
| – | – | ﹤0.01% | 611 |
|
|
2021
Q3 | $31K | Hold |
169
| – | – | ﹤0.01% | 631 |
|
|
2021
Q2 | $34K | Hold |
169
| – | – | ﹤0.01% | 598 |
|
|
2021
Q1 | $36K | Hold |
169
| – | – | ﹤0.01% | 594 |
|
|
2020
Q4 | $40K | Buy |
+169
| New | +$40K | ﹤0.01% | 564 |
|